Arkolith/Insider Trading/LRMR/Form 4

Ben-Maimon Carole

President and CEO, DirectorLarimar Therapeutics, Inc. (LRMR) · full profile →Form 4 · filed May 18, 2023
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 17, 2023Buy(P)5K$3.71$19K267K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-011546) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML